Cholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.
Donepezil, a drug routinely administered to slow cognitive decline in Alzheimer's disease, shows promise in treating damage caused to the brain by adolescent alcohol exposure. The drug reverses neuroinflammation and neuron damage in rats exposed to alcohol during adolescence.
Researchers report a drug used to slow cognitive decline in Alzheimer's disease may help to reverse memory and learning problems in teens who binge drink.
According to a new study, acetylcholinesterase inhibitors commonly used to help treat Alzheimer's disease appear to help smokers reduce cigarette consumption.
A new study reports a drug commonly used to treat Alzheimer's disease appears to effectively reduce bone loss and prevent fractures.
